Dana Investment Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-36,069
Closed -$1.63M 303
2020
Q2
$1.63M Sell
36,069
-3,624
-9% -$162K 0.09% 138
2020
Q1
$1.53M Buy
39,693
+160
+0.4% +$7.37K 0.09% 119
2019
Q4
$1.83M Sell
39,533
-2,302
-6% -$99.7K 0.09% 149
2019
Q3
$1.7M Sell
41,835
-495
-1% -$21.4K 0.09% 156
2019
Q2
$2.04M Buy
42,330
+13,136
+45% +$691K 0.1% 146
2019
Q1
$1.83M Sell
29,194
-1,931
-6% -$133K 0.09% 173
2018
Q4
$1.86M Sell
31,125
-16,928
-35% -$1.02M 0.09% 153
2018
Q3
$3.1M Sell
48,053
-6,921
-13% -$386K 0.13% 120
2018
Q2
$2.47M Sell
54,974
-23,818
-30% -$950K 0.11% 145
2018
Q1
$2.45M Buy
78,792
+317
+0.4% +$10.4K 0.11% 140
2017
Q4
$2.35M Sell
78,475
-308
-0.4% -$8.92K 0.1% 158
2017
Q3
$2.6M Sell
78,783
-3,289
-4% -$114K 0.12% 129
2017
Q2
$2.75M Sell
82,072
-3,621
-4% -$108K 0.13% 127
2017
Q1
$2.48M Buy
+85,693
New +$2.12M 0.12% 146

Other funds holding BEAT

Dana Investment Advisors's BEAT Position: Q3 2020 in Review

Dana Investment Advisors sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 36,069 shares — an estimated $1.63M sold.

Dana Investment Advisors first reported a position in BEAT in Q1 2017 and held it in 14 quarters. The position peaked at $3.1M in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Dana Investment Advisors reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Dana Investment Advisors sold 36,069 BioTelemetry, Inc. shares in Q3 2020, an estimated $1.63M.
  • Dana Investment Advisors first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 14 quarters.
  • Dana Investment Advisors's BioTelemetry, Inc. position peaked at $3.1M in Q3 2018.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Dana Investment Advisors's 13F filing for Q3 2020, filed 10 Nov 2020.